Skyward Specialty Insurance Group, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed on August 15, 2023, regarding events occurring on August 14, 2023. Skyward Specialty Insurance Group, Inc. (SKWD), a Delaware corporation listed on The Nasdaq Stock Market, reported the appointment of a new director to its Board of Directors.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on corporate governance changes and associated compensation arrangements.
Material Changes
The primary material change reported is the appointment of Gena L. Ashe to the Board of Directors, effective August 14, 2023. Key details of this appointment include:
- Role: Class I Director with a term expiring at the 2026 annual meeting.
- Committee Assignments: Chair of the Nominating and Corporate Governance Committee; Member of the Compensation Committee.
- Background: Ms. Ashe brings over 39 years of legal and corporate regulatory expertise, currently serving as General Counsel and Corporate Secretary of Anterix Inc.
Compensation and Governance Details
In accordance with the Company's independent director compensation policy, Ms. Ashe's compensation package includes:
- Base Retainer: $50,000 per year, payable quarterly on a pro-rata basis.
- Equity Award: An annual Restricted Stock Award (RSA) valued at $100,000 of common stock (pro-rated for the first year), vesting in full on the one-year anniversary of the grant date.
- Expenses: Reimbursement for all reasonable expenses related to her services.
- Indemnification: Execution of the Company's standard form of indemnification agreement.
The Board confirmed there are no undisclosed arrangements or understandings regarding Ms. Ashe's election.
Investor Verification Checklist
- Verify the pro-rata calculation for the initial year's base retainer and RSA grant.
- Review the Company's 2022 Long-Term Incentive Plan (Exhibit 10.4 to Form S-1) for specific terms governing the RSA.
- Confirm the impact of the new director on the composition and voting dynamics of the Nominating and Corporate Governance Committee.
- Check for any subsequent filings regarding the vesting schedule or stock price at the time of the RSA grant.